Johnson & Johnson (JNJ) Q1 2026 (USD) : EPS 2.70 (exp. 2.68), Revenue 24.1bln (exp. 23.61bln), Net Income 6.61bln (exp. 6.55bln), Current FY Rev. 100.3-101.3bln (prev. 100-101bln; exp. 100.62bln), quarterly dividend +3.1% to 1.34/shr (prev. 1.30/shr)

Johnson & Johnson's Q1 2026 results beat expectations on both earnings and revenue, demonstrating solid performance driven by its Oncology portfolio.

Newsquawk StaffPublished 14 Apr 2026, 10:40 UTCOn the live feed at 10:20 UTC — 3 more headlines followed before this page went public

Newsquawk headlinesUTC

10:33

JPMorgan Chase & Co. (JPM) Q1 2026 (USD): EPS 5.94 (exp. 5.44), Revenue 49.8bln (exp. 49.13bln), FICC Sales & Trading 7.08bln (exp. 6.65bln), Equities Sales & Trading 4.48bln (exp. 4.31bln), Investment Banking 3.14bln (exp. 2.73bln)

10:29

Wells Fargo & Company (WFC): Q1 2026 (USD) EPS 1.60 (exp. 1.58), Revenue 21.5bln (exp. 21.76bln); affirms FY26 NII 50bln (exp. 50.4bln), expenses 55.7bln (prev. 54.8bln Y/Y), avg. loans "mid-single digits growth" Y/Y

10:20

Johnson & Johnson (JNJ) Q1 2026 (USD) : EPS 2.70 (exp. 2.68), Revenue 24.1bln (exp. 23.61bln), Net Income 6.61bln (exp. 6.55bln), Current FY Rev. 100.3-101.3bln (prev. 100-101bln; exp. 100.62bln), quarterly dividend +3.1% to 1.34/shr (prev. 1.30/shr)

10:17

Reports in Iran state that there is still no information about an agreement to hold talks in Islamabad or in other reports, despite claims by some Pakistani sources and Western media

10:16

EU agrees to double tariffs on foreign steel, according to reports

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free

Free. No signup, no card.

Growth was driven primarily by DARZALEX (GMAB DC), CARVYKTI, ERLEADA, and RYBREVANT/LAZCLUZE in Oncology.
Innovative Medicine worldwide operational sales grew 7.4%*, with net acquisitions and divestitures positively impacting growth by 1.8% primarily due to CAPLYTA.

Context

The upward revision of their full-year revenue guidance signals confidence in sustained growth, while the increased dividend reflects a commitment to returning value to shareholders, enhancing the attractiveness of the stock amidst industry challenges.

FX · last 90 days

Recent headlines that moved markets

FX/28 Aug · 14:00 UTC

Fed Chair Warsh says Fed has more work to do unless confident underlying inflation is moving towards 2% objective

DXY, after we published+0.5%

DXY saw two-way action, before then moving to a high. - Immediately after the release, Fed market pricing moved to price in a 50% chance of a hike in September vs 36% pre-release.

FX/7 Sept · 06:00 UTC

Swedish CPIF Prel (Aug YY) 0.7% vs. Exp. 0.8% (Prev. 0.7%).

With EUR/SEK, after we published+0.3%

FX/4 Sept · 12:39 UTC

Airbus (AIR FP) reportedly reaches a pre-agreement with Spanish unions, Democrata reports.

Market, after we published+1.4%

FX/4 Sept · 12:30 UTC

US Non Farm Payrolls (Aug) 162K vs. Exp. 56K (Prev. 21K); 2-month net revision +55k; Birth-Death 154K.

- DXY, after we published−2.4%

FX/4 Sept · 12:30 UTC

US Non Farm Payrolls (Aug) 162K vs. Exp. 56K (Prev. 21K); 2-month net revision +55k; Birth-Death 154K.

- DXY, after we published+0.4%

FX/4 Sept · 08:30 UTC

BoE DMP (Aug): 1-year CPI expectation 3.1% (prev. 3.4%), 3-year CPI expectation 2.8% (prev. 2.8%).

Market, after we published+0.3%

Newsquawk Daily

Get both market opens in your inbox.

This note and the other one — the EU open and the US open, every business day, written by the desk. No account needed.

Related headlines

The whole workspace, free to try.

© 2026 Newsquawk. All rights reserved.